Rockwell Medical, Inc. (RMTI): Depreciation & Amortization
$2.19M
Year ended 2025-12-31
$2.09M
Trailing 12 months to 2026-06-30
+56.1%
3-year compound annual growth
+21.3%
5-year compound annual growth
+10.3%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.19M | +0.6% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $2.18M | +51.0% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $1.44M | +150.7% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $576.0K | -13.8% | 2024-03-21, From 2022-01-01 |
| 2021-12-31 | $668.0K | -19.9% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $834.0K | +5.8% | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | $788.0K | +21.2% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $650.1K | +26.4% | 2020-03-17, From 2018-01-01 |
| 2017-12-31 | $514.4K | -32.5% | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | $762.4K | -7.3% | 2018-03-15, From 2016-01-01 |
| 2015-12-31 | $822.3K | -17.5% | 2018-03-15, From 2015-01-01 |
| 2014-12-31 | $996.3K | -1.1% | 2017-03-15, From 2014-01-01 |
| 2013-12-31 | $1.01M | -7.4% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $1.09M | -7.5% | 2015-03-03, From 2012-01-01 |
| 2011-12-31 | $1.18M | -15.3% | 2014-03-07, From 2011-01-01 |
| 2010-12-31 | $1.39M | +12.6% | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | $1.23M | n/a | 2012-03-05, From 2009-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Rockwell Medical, Inc. (RMTI) | 2025-12-31 | $2.19M | +0.6% |
| Viridian Therapeutics, Inc. (VRDN) | 2025-12-31 | $460.0K | -14.8% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $0 | -100.0% |
| Assembly Biosciences, Inc. (ASMB) | 2025-12-31 | $129.0K | 0.0% |
| Bicycle Therapeutics PLC (BCYC) | 2025-12-31 | $6.42M | -10.5% |
| Enanta Pharmaceuticals Inc (ENTA) | 2025-09-30 | $4.59M | +96.3% |
| Nuvation Bio Inc. (NUVB) | 2025-12-31 | $1.74M | +154.6% |
| Eton Pharmaceuticals, Inc. (ETON) | 2025-12-31 | $4.04M | +252.9% |
| Arcturus Therapeutics Holdings Inc. (ARCT) | 2025-12-31 | $3.02M | -14.6% |
Compare RMTI, VRDN, SPRO, ASMB side by side · Screen every company in Pharmaceutical Preparations ↗